Literature DB >> 18922024

Carbapenems and SHV-1 beta-lactamase form different acyl-enzyme populations in crystals and solution.

Matthew Kalp1, Paul R Carey.   

Abstract

The reactions between single crystals of the SHV-1 beta-lactamase enzyme and the carbapenems, meropenem, imipenem, and ertapenem, have been studied by Raman microscopy. Aided by quantum mechanical calculations, major populations of two acyl-enzyme species, a labile Delta (2)-pyrroline and a more tightly bound Delta (1)-pyrroline, have been identified for all three compounds. These isomers differ only in the position of the double bond about the carbapenem nucleus. This discovery is consonant with X-ray crystallographic findings that also identified two populations for meropenem bound in SHV-1: one with the acyl CO group in the oxyanion hole and the second with the acyl group rotated 180 degrees compared to its expected position [Nukaga, M., Bethel, C. R., Thomson, J. M., Hujer, A. M., Distler, A. M., Anderson, V. E., Knox, J. R., and Bonomo, R. A. (2008) J. Am. Chem. Soc. (in press)]. When crystals of the Delta (1)- and Delta (2)-containing acyl-enzymes were exposed to solutions with no carbapenem, rapid deacylation of the Delta (2) species was observed by kinetic Raman experiments. However, no change in the Delta (1) population was observed over 1 h, the effective lifetime of the crystal. These observations lead to the hypothesis that the stable Delta (1) species is due to the form seen by X-ray with the acyl carbonyl outside the oxyanion hole, while the Delta (2) species corresponds to the form with the carbonyl inside the oxyanion hole. Soak-in and soak-out Raman experiments also demonstrated that tautomeric exchange between the Delta (1) and Delta (2) forms does not occur on the crystalline enzyme. When meropenem or ertapenem was reacted with SHV-1 in solution, the Raman difference spectra demonstrated that only a major population corresponding to the Delta (1) acyl-enzyme could be detected. The 1003 cm (-1) mode of the phenyl ring positioned on the C3 side chain of ertapenem acts as an effective internal Raman intensity standard, and the ratio of its intensity to that of the 1600 cm (-1) feature of Delta (1) provides an estimate of the relative populations of Delta (1). In solution, I 1600/ I 1003 equals 2, and in the crystal, I 1600 /I 1003 equals 1. This is strong evidence that the Delta (1) and Delta (2) acyl-enzymes in the crystal are present in approximately equal amounts, in agreement with the X-ray data. However, in solution there are twice as many Delta (1) species per Phe group, and this represents approximately 100% of the active sites, which is consistent with the observed inhibition of the enzyme's activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18922024      PMCID: PMC2656688          DOI: 10.1021/bi800833u

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  b-Lactamase inhibitors.

Authors:  Malcolm G. P. Page
Journal:  Drug Resist Updat       Date:  2000-04       Impact factor: 18.500

Review 2.  Raman crystallography and other biochemical applications of Raman microscopy.

Authors:  Paul R Carey
Journal:  Annu Rev Phys Chem       Date:  2006       Impact factor: 12.703

Review 3.  Spectroscopic characterization of distortion in enzyme complexes.

Authors:  Paul R Carey
Journal:  Chem Rev       Date:  2006-08       Impact factor: 60.622

4.  Probing active site chemistry in SHV beta-lactamase variants at Ambler position 244. Understanding unique properties of inhibitor resistance.

Authors:  Jodi M Thomson; Anne M Distler; Fabio Prati; Robert A Bonomo
Journal:  J Biol Chem       Date:  2006-06-27       Impact factor: 5.157

Review 5.  OXA (beta)-lactamases in Acinetobacter: the story so far.

Authors:  Susan Brown; Sebastian Amyes
Journal:  J Antimicrob Chemother       Date:  2005-12-06       Impact factor: 5.790

6.  Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem.

Authors:  L Pernot; F Frénois; T Rybkine; G L'Hermite; S Petrella; J Delettré; V Jarlier; E Collatz; W Sougakoff
Journal:  J Mol Biol       Date:  2001-07-20       Impact factor: 5.469

7.  Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.

Authors:  Monica A Totir; Pius S Padayatti; Marion S Helfand; Marianne P Carey; Robert A Bonomo; Paul R Carey; Focco van den Akker
Journal:  Biochemistry       Date:  2006-10-03       Impact factor: 3.162

8.  Inhibition of the RTEM beta-lactamase from Escherichia coli. Interaction of the enzyme with derivatives of olivanic acid.

Authors:  C J Easton; J R Knowles
Journal:  Biochemistry       Date:  1982-06-08       Impact factor: 3.162

9.  Inhibition of class A beta-lactamases by carbapenems: crystallographic observation of two conformations of meropenem in SHV-1.

Authors:  Michiyosi Nukaga; Christopher R Bethel; Jodi M Thomson; Andrea M Hujer; Anne Distler; Vernon E Anderson; James R Knox; Robert A Bonomo
Journal:  J Am Chem Soc       Date:  2008-08-30       Impact factor: 15.419

10.  Inhibition of the RTEM beta-lactamase from Escherichia coli. Interaction of enzyme with derivatives of olivanic acid.

Authors:  R L Charnas; J R Knowles
Journal:  Biochemistry       Date:  1981-05-12       Impact factor: 3.162

View more
  18 in total

1.  Structures of the Michaelis complex (1.2 Å) and the covalent acyl intermediate (2.0 Å) of cefamandole bound in the active sites of the Mycobacterium tuberculosis β-lactamase K73A and E166A mutants.

Authors:  Lee W Tremblay; Hua Xu; John S Blanchard
Journal:  Biochemistry       Date:  2010-10-25       Impact factor: 3.162

2.  Biochemical and structural characterization of Mycobacterium tuberculosis beta-lactamase with the carbapenems ertapenem and doripenem.

Authors:  Lee W Tremblay; Fan Fan; John S Blanchard
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

Review 3.  Carbapenems: past, present, and future.

Authors:  Krisztina M Papp-Wallace; Andrea Endimiani; Magdalena A Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

4.  Structures of the class D carbapenemase OXA-24 from Acinetobacter baumannii in complex with doripenem.

Authors:  Kyle D Schneider; Caleb J Ortega; Nicholas A Renck; Robert A Bonomo; Rachel A Powers; David A Leonard
Journal:  J Mol Biol       Date:  2011-01-06       Impact factor: 5.469

Review 5.  Kinetic crystallography by Raman microscopy.

Authors:  Paul R Carey; Yuanyuan Chen; Bo Gong; Matthew Kalp
Journal:  Biochim Biophys Acta       Date:  2010-08-23

6.  Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design.

Authors:  Sarah M Drawz; Maja Babic; Christopher R Bethel; Magda Taracila; Anne M Distler; Claudia Ori; Emilia Caselli; Fabio Prati; Robert A Bonomo
Journal:  Biochemistry       Date:  2010-01-19       Impact factor: 3.162

7.  The binding of antibiotics in OmpF porin.

Authors:  Brigitte K Ziervogel; Benoît Roux
Journal:  Structure       Date:  2012-11-29       Impact factor: 5.006

Review 8.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

9.  The 1.4 A crystal structure of the class D beta-lactamase OXA-1 complexed with doripenem.

Authors:  Kyle D Schneider; Mary E Karpen; Robert A Bonomo; David A Leonard; Rachel A Powers
Journal:  Biochemistry       Date:  2009-12-22       Impact factor: 3.162

10.  Mechanistic Basis of OXA-48-like β-Lactamases' Hydrolysis of Carbapenems.

Authors:  Vlatko Stojanoski; Liya Hu; Banumathi Sankaran; Feng Wang; Peng Tao; B V Venkataram Prasad; Timothy Palzkill
Journal:  ACS Infect Dis       Date:  2021-01-25       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.